The value of nephrectomy in metastatic renal-cell cancer has long been debated. Several nonrandomized studies suggest a higher rate of response to systemic therapy and longer survival in patients who ...

BOSTON -- Surgery to remove a cancerous kidney can often lengthen the lives of patients receiving targeted therapy for metastatic kidney cancer, but only about three in ten such patients undergo the ...

Increased detection of the small renal mass over the last two decades has led to greater utilization of partial nephrectomy techniques. Appreciation of the negative impact of chronic renal impairment ...

Kidney cancer is one of the few malignancies in which surgical resection of the primary disease, or cytoreductive nephrectomy, has held tremendous importance. Historically, systemic therapy was ...

Cytoreductive nephrectomy may offer an overall survival benefit to patients with metastatic kidney cancer who are treated with targeted therapies, researchers have found. Surgery to remove a cancerous ...